Skip to main content

Advertisement

SpringerLink
Log in

The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

To determine the prevalence, clinical and radiological characteristics of spondyloarthropathy (SpA) in patients with inflammatory bowel disease (IBD), to assess the association between HLA B27 and B51 and the extraintestinal symptoms and to evaluate whether IBD is associated with Behçet’s disease (BD). One hundred and sixty-two consecutive adult patients with established diagnosis of IBD as either Crohn’s disease (CD) or ulcerative colitis (UC) were evaluated. All the patients including those previously diagnosed with or without SpA had a complete rheumatologic examination and they were evaluated according to the European Spondyloarthropathy Study Group (ESSG) criteria for SpA and The International Study Group for Behçet’s disease criteria for BD. The demographic and clinical data were recorded on a standardized form. The radiographies were obtained in all the patients and computed tomography (CT) was performed in the patients with suspected pelvic radiographies and/or low back pain in the physical examination. Radiological evaluation was made according to the Modified New York criteria. HLA B27, B51 and anti-neutrophile cytoplasmic antigen (ANCA) were searched in all the patients. Of the 162 patients with IBD (mean age 41.48±11.63 years, male 60, female 102), 78 were CD and 84 were UC. The mean of the IBD duration was 54.92±50.32 months and SpA duration was 20.63±34.37 months. The prevalence of SpA and AS in IBD was 45.7 and 9.9%, respectively. Frequencies of SpA and AS, the difference between UC and CD were not significant. Spondylitis, enthesitis, peripheral arthritis, oral ulcer and uveitis were not different between UC and CD, but erythema nodosum was found significantly more common in the CD patients compared with UC patients (P=0.005). The duration of IBD and SpA was similar in both groups. As the IBD duration increased, the prevalence of SpA development decreased (rr=0.991, P=0.009). Of the IBD patients, 13.6% were asymptomatic for musculoskeletal manifestations of SpA and their sacroiliac radiographies and CTs showed grade 2 sacroiliitis. HLA B27, B51 and ANCA positivities were not different between the patients with UC and CD. HLA B27 was significantly more common in the patients with sacroiliitis, spondylitis, enthesitis, peripheral arthritis, erythema nodosum, uveitis (P<0.001) and oral ulcer (P=0.025). BD was diagnosed in none of the patients. ANCA positivity was found to be related with the presence of erythema nodosum and uveitis (P=0.001 and P=0.005). The prevalence of SpA and AS is higher in the prospectively evaluated patients with radiological studies than those in the previously published studies. There is a high prevalence of asymptomatic sacroiliitis in IBD. An early diagnosis of inflammatory arthritis in IBD patients may prevent a disability due to SpA and AS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Baeten D, De Keyser F, Mielants H, Veys EM (2002) Ankylosing spondylitis and bowel disease. B Pract Res Clin Rheumatol 16:537–549

    Article  Google Scholar 

  2. Smale S, Natt RS, Orchard TR, Russel AS, Bjarnason I (2001) Inflammatory bowel disease and spondyloarthropathy. Arthritis Rheum 44:2728–2736

    Article  PubMed  CAS  Google Scholar 

  3. Gravallese EM, Kantrowitz FG (1988) Arthritic manifestations of inflammatory bowel disease. Am J Gastroenterol 83:703–709

    PubMed  CAS  Google Scholar 

  4. Schorr-Lesnick B, Brandt LJ (1988) Selected rheumatologic and dermatologic manifestations of inflammatory bowel disease. Am J Gastroenterol 83:216–223

    PubMed  CAS  Google Scholar 

  5. Khan MA (2002) Update on spondyloarthropathies. Ann Intern Med 136:896–907

    PubMed  Google Scholar 

  6. Kidd BI, Cawley MI (1988) Delay in diagnosis of spondylarthritis. Br J Rheumatol 27:230–232

    Article  PubMed  CAS  Google Scholar 

  7. Boyer GS, Templin DW, Bowler A, Lawrence RC, Heyse SP, Everett DF et al (1997) A comparison of patients with spondyloarthropathy seen in specialty clinics with those identified in a community wide epidemiologic study. Has the classic case misled us? Arch Intern Med 157:2111–2117

    Article  PubMed  CAS  Google Scholar 

  8. Spoorenberg A, van der Hejde D, de Klerk E, Dougados M, de Vlam K, Mielents H et al (1999) Relative values of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26:980–984

    PubMed  CAS  Google Scholar 

  9. Salvarani C, Vlachonikolis IG, van der Heijde DM, Fornaciari G, Macchioni P, Beltrami M et al (2001) Musculoskeletal manifestation in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 36:1307–1313

    Article  PubMed  CAS  Google Scholar 

  10. de Vlam K, Mielants H, Cuvelier C, de Keyser F, Veys EM, de Vos M (2000) Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol 27:2860–2865

    PubMed  Google Scholar 

  11. Palm O, Moum B, Ongre A, Gran JT (2002) Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (The IBSEN Study). J Rheumatol 29:511–515

    PubMed  Google Scholar 

  12. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N (2001) The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 96:1116–1122

    Article  PubMed  CAS  Google Scholar 

  13. Gul A, Uyar FA, Inanc M, Ocal L, Barrett JH, Aral H et al (2002) A weak association of HLA-B*2702 with Behcet’s disease. Genes Immun 3:368–372

    Article  PubMed  CAS  Google Scholar 

  14. Houman H, Ben Dahmen F, Ben Ghorbel I, Chouaib S, Lamloum M, Kchir N et al (2001) Behcet’s disease associated with Crohn’s disease. Ann Med Interne (Paris) 152:480–482

    CAS  Google Scholar 

  15. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A et al (1991) The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 34:1218–1227

    Article  PubMed  CAS  Google Scholar 

  16. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368

    Article  PubMed  Google Scholar 

  17. International Study Group for Behçet’s Disease: criteria for diagnosis of Behçet’s disease (1990) Lancet 335:1078–1080

  18. Steer S, Jones H, Hibbert J, Kondeatis E, Vaughan R, Sanderson J et al (2003) Low back pain, sacroiliitis, and the relation with HLA-B27 in Crohn’s disease. J Rheumatol 30:518–522

    PubMed  Google Scholar 

  19. Scarpa R, Del Puente A, D’Arienzo A, di Girolamo C, della Valle G, Panarese A (1992) The arthritis of ulcerative colitis: clinical and genetical aspects. J Rheumatol 19:373–377

    PubMed  CAS  Google Scholar 

  20. Orchard TR, Wordsworth BP, Jewell DP (1998) Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 42:387–391

    Article  PubMed  CAS  Google Scholar 

  21. Scott WW, Fishman EK, Kuhlman JE, Caskey CI, O’Brien JJ, Walia GS et al (1990) Computed tomography evaluation of the sacroiliac joints in Crohn’s disease. Radiologic/clinical correlation. Skeleton Radiol 19:207–210

    Google Scholar 

  22. Queri R, Maiz O, Intxausti J, de Dios JR, Belzunegui J, Gonzalez C et al (2000) Subclinic sacroiliitis in inflammatory bowel disease: a clinical and follow-up study. Clin Rheumatol 19:445–449

    Article  PubMed  Google Scholar 

  23. McEniff N, Eustace S, McCharthy C, O’Malley M, O’Morain CA, Hamilton S (1995) Asymptomatic sacroiliitis in inflammatory bowel disease. Assessment by computed tomography. Clin Imaging 19:258–262

    Article  PubMed  CAS  Google Scholar 

  24. Leirisalo-Repo M, Turunen U, Stenman S, Helenius P, Seppala K (1994) High frequency of silent inflammatory bowel disease in spondyloarthropathy. Arthritis Rheum 37:23–31

    Article  PubMed  CAS  Google Scholar 

  25. Mielants H, De Vos M, Cuvelier C, Veys EM (1996) The role of gut inflammation in the pathogenesis of spondyloarthropathies. Acta Clin Belg 51:340–349

    PubMed  CAS  Google Scholar 

  26. Torok HP, Glas J, Gruber R, Brumberger V, Strasser C, Kellner H et al (2004) Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: increased prevalence of ASCA and pANCA. Digestion 70:49–54

    Article  PubMed  Google Scholar 

  27. Picco P, Gattorno M, Vignola S, Barabino A, Marazzi MG, Bondi E et al (1999) Clinical and biological characteristics of immunopathological disease-related erythema nodosum in children. Scand J Rheumatol 28:27–32

    Article  PubMed  CAS  Google Scholar 

  28. Gordon LK, Eggene M, Holland GN, Weisz JM, Braun J (1998) pANCA antibodies in patients with anterior uveitis: identification of a marker antibody usually associated with ulcerative colitis. J Clin Immunol 18:264–271

    Article  PubMed  CAS  Google Scholar 

  29. Oguz FS, Ocal L, Diler AS, Ozkul H, Asicioglu F, Kasapoglu E et al (2004) HLA B-27 subtypes in Turkish patients with spondyloarthropathy and healthy controls. Dis Markers 20:309–312

    PubMed  CAS  Google Scholar 

  30. Pirim I, Atasoy M, Ikbal M, Erdem T, Aliagaoglu C (2004) HLA class I and II genotyping in patients with Behcet’s disease: a regional study of eastern part of Turkey. Tissue Antigens 64:293–297

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine, Department of Clinical Immunology and Rheumatology, Ankara University, 4. Sok. 22/50 Manolya Apt. Sogutozu, 06520, Ankara, Turkey

    Nuran Turkcapar, Olcay Tiryaki Aydintug, Nursen Duzgun & Murat Duman

  2. School of Medicine, Department of Gastroenterology, Ankara University, Ankara, Turkey

    Murat Toruner, Irfan Soykan, Hulya Cetinkaya & Ali Ozden

Authors
  1. Nuran Turkcapar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Murat Toruner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Irfan Soykan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Olcay Tiryaki Aydintug
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hulya Cetinkaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nursen Duzgun
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ali Ozden
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Murat Duman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nuran Turkcapar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Turkcapar, N., Toruner, M., Soykan, I. et al. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatol Int 26, 663–668 (2006). https://doi.org/10.1007/s00296-005-0044-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-005-0044-9

Keywords

Search

Navigation